Suk Woo Nam

Author PubWeight™ 117.03‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas. Oncogene 2005 4.07
2 Somatic mutations of ERBB2 kinase domain in gastric, colorectal, and breast carcinomas. Clin Cancer Res 2006 1.98
3 Increased expression of histone deacetylase 2 is found in human gastric cancer. APMIS 2005 1.77
4 Autotaxin hydrolyzes sphingosylphosphorylcholine to produce the regulator of migration, sphingosine-1-phosphate. Cancer Res 2003 1.73
5 Somatic mutations of EGFR gene in squamous cell carcinoma of the head and neck. Clin Cancer Res 2005 1.70
6 Inactivating mutations of caspase-8 gene in colorectal carcinomas. Gastroenterology 2003 1.56
7 Sirtuin7 oncogenic potential in human hepatocellular carcinoma and its regulation by the tumor suppressors MiR-125a-5p and MiR-125b. Hepatology 2013 1.49
8 Somatic mutations of the ERBB4 kinase domain in human cancers. Int J Cancer 2006 1.38
9 BRAF and KRAS mutations in stomach cancer. Oncogene 2003 1.27
10 Genetic alterations of the KLF6 gene in gastric cancer. Oncogene 2005 1.26
11 ArrayCyGHt: a web application for analysis and visualization of array-CGH data. Bioinformatics 2005 1.23
12 Altered expression of the KLF4 in colorectal cancers. Pathol Res Pract 2006 1.23
13 CASPASE-8 gene is inactivated by somatic mutations in gastric carcinomas. Cancer Res 2005 1.20
14 Mutational analysis of EGFR and K-RAS genes in lung adenocarcinomas. Virchows Arch 2005 1.20
15 ERBB2 kinase domain mutation in the lung squamous cell carcinoma. Cancer Lett 2005 1.19
16 MiR-145 functions as a tumor suppressor by directly targeting histone deacetylase 2 in liver cancer. Cancer Lett 2013 1.17
17 Decreased expression of tumour suppressor Bax-interacting factor-1 (Bif-1), a Bax activator, in gastric carcinomas. Pathology 2006 1.16
18 Aberrant regulation of HDAC2 mediates proliferation of hepatocellular carcinoma cells by deregulating expression of G1/S cell cycle proteins. PLoS One 2011 1.12
19 Mutations of beta-catenin and AXIN I genes are a late event in human hepatocellular carcinogenesis. Liver Int 2005 1.11
20 Caspase-8 gene is frequently inactivated by the frameshift somatic mutation 1225_1226delTG in hepatocellular carcinomas. Oncogene 2005 1.09
21 Targeted disruption of Nemo-like kinase inhibits tumor cell growth by simultaneous suppression of cyclin D1 and CDK2 in human hepatocellular carcinoma. J Cell Biochem 2010 1.07
22 Loss of caspase-2, -6 and -7 expression in gastric cancers. APMIS 2004 1.06
23 Correlation of KIT and platelet-derived growth factor receptor alpha mutations with gene activation and expression profiles in gastrointestinal stromal tumors. Oncogene 2005 1.06
24 Somatic mutations of CASP3 gene in human cancers. Hum Genet 2004 1.05
25 Overexpression of S100A4 is closely related to the aggressiveness of gastric cancer. APMIS 2003 1.05
26 Inactivation of the Gastrokine 1 gene in gastric adenomas and carcinomas. J Pathol 2011 1.04
27 Supported core@shell electrocatalysts for fuel cells: close encounter with reality. Sci Rep 2013 1.03
28 Gastrokine 1 functions as a tumor suppressor by inhibition of epithelial-mesenchymal transition in gastric cancers. J Cancer Res Clin Oncol 2011 1.01
29 PDCD4 expression inversely correlated with miR-21 levels in gastric cancers. J Cancer Res Clin Oncol 2012 1.01
30 Mutational analysis of AKT1, AKT2 and AKT3 genes in common human carcinomas. Oncology 2006 1.00
31 Genetic alterations of the ATBF1 gene in gastric cancer. Clin Cancer Res 2007 0.99
32 GKN1-miR-185-DNMT1 axis suppresses gastric carcinogenesis through regulation of epigenetic alteration and cell cycle. Clin Cancer Res 2013 0.97
33 Inactivating mutations of CASPASE-7 gene in human cancers. Oncogene 2003 0.96
34 Genetic and epigenetic alterations of the KLF6 gene in hepatocellular carcinoma. J Gastroenterol Hepatol 2006 0.95
35 HDAC2 overexpression confers oncogenic potential to human lung cancer cells by deregulating expression of apoptosis and cell cycle proteins. J Cell Biochem 2012 0.95
36 Hypermethylation of the RUNX3 gene in hepatocellular carcinoma. Exp Mol Med 2005 0.93
37 ERBB3 kinase domain mutations are rare in lung, breast and colon carcinomas. Int J Cancer 2006 0.92
38 Inactivating mutations of the Siah-1 gene in gastric cancer. Oncogene 2004 0.92
39 Different gene expression profiles between microsatellite instability-high and microsatellite stable colorectal carcinomas. Oncogene 2004 0.92
40 Suppression of metastasis of intravenously-inoculated B16/F10 melanoma cells by the novel ginseng-derived ingredient, gintonin: involvement of autotaxin inhibition. Int J Oncol 2012 0.92
41 Increased expression of Gab2, a scaffolding adaptor of the tyrosine kinase signalling, in gastric carcinomas. Pathology 2007 0.92
42 Differential gene expression profiles of metastases in paired primary and metastatic colorectal carcinomas. Oncology 2008 0.92
43 DBC1 does not function as a negative regulator of SIRT1 in liver cancer. Oncol Lett 2012 0.91
44 HDAC1 inactivation induces mitotic defect and caspase-independent autophagic cell death in liver cancer. PLoS One 2012 0.91
45 Mechanisms of enhanced sulfur tolerance on samarium (Sm)-doped cerium oxide (CeO2) from first principles. Phys Chem Chem Phys 2014 0.90
46 Somatic mutations of the beta-TrCP gene in gastric cancer. APMIS 2007 0.90
47 Altered expression of KCNK9 in colorectal cancers. APMIS 2004 0.90
48 Overexpression of serine-threonine receptor kinase-associated protein in colorectal cancers. Pathol Int 2007 0.89
49 Histone deacetylase 6 functions as a tumor suppressor by activating c-Jun NH2-terminal kinase-mediated beclin 1-dependent autophagic cell death in liver cancer. Hepatology 2012 0.89
50 Palladium catalysts for dehydrogenation of ammonia borane with preferential B-H activation. J Am Chem Soc 2010 0.88
51 Inactivating mutation of the pro-apoptotic gene BID in gastric cancer. J Pathol 2004 0.88
52 Aspartic acid repeat polymorphism of the asporin gene with susceptibility to osteoarthritis of the knee in a Korean population. Knee 2008 0.88
53 TNF-α and TNF-β Polymorphisms are Associated with Susceptibility to Osteoarthritis in a Korean Population. Korean J Pathol 2012 0.87
54 Targeted disruption of S100P suppresses tumor cell growth by down-regulation of cyclin D1 and CDK2 in human hepatocellular carcinoma. Int J Oncol 2009 0.87
55 Gastrokine 1 regulates NF-κB signaling pathway and cytokine expression in gastric cancers. J Cell Biochem 2013 0.87
56 Application of concave microwells to pancreatic tumor spheroids enabling anticancer drug evaluation in a clinically relevant drug resistance model. PLoS One 2013 0.87
57 Inactivating mutations of proapoptotic Bad gene in human colon cancers. Carcinogenesis 2004 0.87
58 ERBB2 kinase domain mutation in a gastric cancer metastasis. APMIS 2005 0.86
59 Functional analysis of the NH2-terminal hydrophobic region and BRICHOS domain of GKN1. Biochem Biophys Res Commun 2013 0.86
60 HDAC2 provides a critical support to malignant progression of hepatocellular carcinoma through feedback control of mTORC1 and AKT. Cancer Res 2014 0.86
61 Identification of frequently mutated genes with relevance to nonsense mediated mRNA decay in the high microsatellite instability cancers. Int J Cancer 2010 0.86
62 A single nucleotide polymorphism in the E-cadherin gene promoter-160 is not associated with risk of Korean gastric cancer. J Korean Med Sci 2003 0.86
63 Gene expression changes in patient-matched gastric normal mucosa, adenomas, and carcinomas. Exp Mol Pathol 2010 0.86
64 Absence of EGFR mutation in the kinase domain in common human cancers besides non-small cell lung cancer. Int J Cancer 2005 0.86
65 Genetic analysis of the DBC2 gene in gastric cancer. Acta Oncol 2007 0.85
66 Colorectal tumors frequently express phosphorylated mitogen-activated protein kinase. APMIS 2004 0.85
67 Targeted inactivation of HDAC2 restores p16INK4a activity and exerts antitumor effects on human gastric cancer. Mol Cancer Res 2012 0.85
68 GKN2 contributes to the homeostasis of gastric mucosa by inhibiting GKN1 activity. J Cell Physiol 2014 0.85
69 Decreased expression of annexin A10 in gastric cancer and its overexpression in tumor cell growth suppression. Oncol Rep 2010 0.84
70 Activation-induced cytidine deaminase expression in gastric cancer. Tumour Biol 2008 0.84
71 Application of amplified RNA and evaluation of cRNA targets for spotted-oligonucleotide microarray. Biochem Biophys Res Commun 2004 0.84
72 Genetic and epigenetic analysis of the KLF4 gene in gastric cancer. APMIS 2007 0.84
73 Aberrant expression of SOX9 is associated with gastrokine 1 inactivation in gastric cancers. Gastric Cancer 2013 0.84
74 Autotaxin (lysoPLD/NPP2) protects fibroblasts from apoptosis through its enzymatic product, lysophosphatidic acid, utilizing albumin-bound substrate. Biochem Biophys Res Commun 2005 0.83
75 Programmed cell death 6 (PDCD6) as a prognostic marker for gastric cancers. Tumour Biol 2011 0.83
76 Immunohistochemical and mutational analysis of apoptosis-inducing factor (AIF) in colorectal carcinomas. APMIS 2006 0.83
77 Immunohistochemical analysis of apoptosis-inducing factor (AIF) expression in gastric carcinomas. Pathol Res Pract 2006 0.83
78 Mutational analysis of the CASP6 gene in colorectal and gastric carcinomas. APMIS 2006 0.83
79 Mutational analysis of the ARAF gene in human cancers. APMIS 2005 0.82
80 Association of IL-17A and IL-17F single nucleotide polymorphisms with susceptibility to osteoarthritis in a Korean population. Gene 2013 0.82
81 Genetic alterations of the MYH gene in gastric cancer. Oncogene 2004 0.82
82 Systemic cell-cycle suppression by Apicidin, a histone deacetylase inhibitor, in MDA-MB-435 cells. Int J Mol Med 2009 0.81
83 Discriminating the molecular basis of hepatotoxicity using the large-scale characteristic molecular signatures of toxicants by expression profiling analysis. Toxicology 2008 0.81
84 The RNA-binding protein HuD regulates autophagosome formation in pancreatic β cells by promoting autophagy-related gene 5 expression. J Biol Chem 2013 0.81
85 BH3 domain mutation of proapoptotic genes Bad, Bmf and Bcl-G is rare in transitional cell carcinomas of the urinary bladder. Pathology 2006 0.81
86 Genetic alterations of the KLF6 gene in colorectal cancers. APMIS 2006 0.81
87 Absence of E17K mutation in the pleckstrin homology domain of AKT1 in gastrointestinal and liver cancers in the Korean population. APMIS 2008 0.80
88 Altered expression of CDX2 in colorectal cancers. APMIS 2006 0.80
89 Mutational analysis of PDPK1 kinase domain in gastric, colorectal and lung carcinomas. Acta Oncol 2006 0.80
90 Mutational analysis of proapoptotic caspase-9 gene in common human carcinomas. APMIS 2006 0.80
91 MYC-regulated genes involved in liver cell dysplasia identified in a transgenic model of liver cancer. J Pathol 2012 0.80
92 Expression of nuclear and cytoplasmic phosphorylated FADD in gastric cancers. Pathol Res Pract 2007 0.80
93 Mutational analysis of PTPRT phosphatase domains in common human cancers. APMIS 2007 0.80
94 Genetic alterations of the Cdx2 gene in gastric cancer. APMIS 2008 0.80
95 Kinase domain mutation of ERBB family genes is uncommon in acute leukemias. Leuk Res 2005 0.79
96 Effect of morphology of electrodeposited Ni catalysts on the behavior of bubbles generated during the oxygen evolution reaction in alkaline water electrolysis. Chem Commun (Camb) 2013 0.79
97 Lysyl oxidase G473A polymorphism is closely associated with susceptibility to gastric cancer in a South Korean population. APMIS 2011 0.79
98 Tetraglyme-mediated synthesis of Pd nanoparticles for dehydrogenation of ammonia borane. Chem Commun (Camb) 2012 0.79
99 JAK2 V617F mutation is uncommon in non-Hodgkin lymphomas. Leuk Lymphoma 2006 0.79
100 Genetic and expression analysis of the KCNRG gene in hepatocellular carcinomas. Exp Mol Med 2006 0.78
101 Identification of characteristic molecular signature for volatile organic compounds in peripheral blood of rat. Toxicol Appl Pharmacol 2010 0.78
102 SOCS5 and SOCS6 have similar expression patterns in normal and cancer tissues. Tumour Biol 2011 0.78
103 Mitochondrial microsatellite instability of colorectal cancer stroma. Int J Cancer 2006 0.78
104 Association of SOD1 and SOD2 single nucleotide polymorphisms with susceptibility to gastric cancer in a Korean population. APMIS 2012 0.78
105 Mutational analysis of the kinase domain of MYLK2 gene in common human cancers. Pathol Res Pract 2006 0.78
106 Genetic and epigenetic analysis of the EPHB2 gene in gastric cancers. APMIS 2007 0.78
107 Mutational analysis of MYC in common epithelial cancers and acute leukemias. APMIS 2006 0.78
108 Identification of large-scale molecular changes of Autotaxin(ENPP2) knock-down by small interfering RNA in breast cancer cells. Mol Cell Biochem 2006 0.78
109 Analysis of succinate dehydrogenase subunit B gene alterations in gastric cancers. Pathol Int 2010 0.78
110 Absence of DKC1 exon 3 mutation in common human cancers. Acta Oncol 2006 0.77
111 Identification of characteristic molecular signature of Müllerian inhibiting substance in human HPV-related cervical cancer cells. Int J Oncol 2011 0.77
112 Molecular integration of HoxB4 and STAT3 for self-renewal of hematopoietic stem cells: a model of molecular convergence for stemness. Stem Cells 2014 0.77
113 Somatic mutation of pro-apoptosis caspase-6 gene is rare in breast and lung carcinomas. Pathology 2006 0.77
114 Characteristic molecular signature for the early detection and prediction of polycyclic aromatic hydrocarbons in rat liver. Toxicol Lett 2012 0.77
115 Genetic alterations and expression pattern of CEACAM1 in colorectal adenomas and cancers. Pathol Oncol Res 2010 0.77
116 Absence of JAK2 V617F mutation in gastric cancers. Acta Oncol 2006 0.76
117 Transcriptional profiling and Wnt signaling activation in proliferation of human hepatic stellate cells induced by PDGF-BB. Korean J Hepatol 2009 0.76
118 Identification of post-generation effect of 3,4-methylenedioxymethamphetamine on the mouse brain by large-scale gene expression analysis. Toxicol Lett 2010 0.76
119 Characteristic molecular signature for early detection and prediction of persistent organic pollutants in rat liver. Environ Sci Technol 2012 0.76
120 Characteristic molecular and proteomic signatures of drug-induced liver injury in a rat model. J Appl Toxicol 2014 0.76
121 Genetic and epigenetic analysis of the VHL gene in gastric cancers. Acta Oncol 2008 0.76
122 Molecular signature for early detection and prediction of polycyclic aromatic hydrocarbons in peripheral blood. Environ Sci Technol 2010 0.76
123 Transcriptomic configuration of mouse brain induced by adolescent exposure to 3,4-methylenedioxymethamphetamine. Toxicol Appl Pharmacol 2009 0.76
124 O⁶-methylguanine-DNA-methyltransferase promoter methylation assessment by microdissection-assisted methylation-specific PCR and high resolution melting analysis in patients with glioblastomas. J Neurooncol 2011 0.76
125 Mutation of FADD gene is rare in human colon and stomach cancers. APMIS 2004 0.75
126 Characteristic molecular signatures of early exposure to volatile organic compounds in rat liver. Biomarkers 2013 0.75
127 Carbon dioxide conversion into hydrocarbon fuels on defective graphene-supported Cu nanoparticles from first principles. Nanoscale 2014 0.75
128 A highly active and durable Co-N-C electrocatalyst synthesized using exfoliated graphitic carbon nitride nanosheets. Nanoscale 2015 0.75
129 Mutational analysis of the HIPK2 gene in keratoacanthoma and squamous cell carcinoma of the skin. APMIS 2011 0.75
130 Kinase domain mutation of MAP2K4 is rare in gastric, colorectal and lung carcinomas. Pathology 2006 0.75
131 Mutational analysis of P-loop domains of proapoptotic Nod1 and ARTS genes in colon carcinomas. Acta Oncol 2006 0.75
132 Highly efficient and durable TiN nanofiber electrocatalyst supports. Nanoscale 2015 0.75
133 Kinase domain mutation of NTRK3 gene is uncommon in gastric carcinomas. Acta Oncol 2005 0.75
134 Mutational analysis of salvador gene in human carcinomas. APMIS 2003 0.75
135 Absence of the mutation of serine/threonine kinase genes AKT2 and MYLK2 in acute leukemias. Eur J Haematol 2006 0.75
136 Absence of BH3 domain mutations in the proapoptotic Bcl-2 gene family in non-Hodgkin lymphomas. Acta Haematol 2006 0.75
137 Absence of the ERBB2 kinase domain mutation in lung adenocarcinomas in Korean patients. Int J Cancer 2005 0.75
138 Extension of the surfactant bridge model for the electrorheological effects of surfactant-activated suspensions. J Colloid Interface Sci 2004 0.75
139 Pin1 gene mutation is a rare event in gastric cancer. APMIS 2006 0.75
140 Enhanced Selectivity to H2 Formation in Decomposition of HCOOH on the Ag19@Pd60 Core-Shell Nanocluster from First-Principles. J Nanosci Nanotechnol 2015 0.75
141 Down-regulation of transforming growth factor beta receptor type III in hepatocellular carcinoma is not directly associated with genetic alterations or loss of heterozygosity. Oncol Rep 2009 0.75
142 Metal-free, polyether-mediated H2-release from ammonia borane: roles of hydrogen bonding interactions in promoting dehydrogenation. Phys Chem Chem Phys 2013 0.75
143 SMAC/DIABLO mutation is uncommon in gastric and colorectal carcinomas. Pathology 2006 0.75
144 Convenient metal embedment into mesoporous silica channels for high catalytic performance in AB dehydrogenation. Chem Commun (Camb) 2013 0.75